Clinical Trial

Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma

Name: Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma — clinical trial record (NCT06405321)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This multicenter retrospective study which included patients with hepatocellular carcinoma (HCC) who received conversion or neoadjuvant therapy to explore the best treatment options and the best benefit group.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2024-05-04; most recent amendment 2026-01-13.

Trial Details

NCT Number	NCT06405321
Lead Sponsor	Guangxi Medical University
Conditions	Hepatocellular Carcinoma
Enrollment	2,000 participants
Start Date	2019-01-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-14